Right-sided colon cancer showed elevated expression of programmed cell death protein-1 (PD-1), suggesting that these patients might respond better to treatments with immune checkpoint inhibitors (Liu D. et al., 2024). Here, PDCD1 is linked to colonic neoplasm.